NIKITA Drug Patent Profile
✉ Email this page to a colleague
When do Nikita patents expire, and when can generic versions of Nikita launch?
Nikita is a drug marketed by Lupin Ltd and is included in one NDA.
The generic ingredient in NIKITA is pitavastatin sodium. There are fifteen drug master file entries for this compound. Additional details are available on the pitavastatin sodium profile page.
Summary for NIKITA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Patent Applications: | 5,679 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NIKITA at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NIKITA
US Patents and Regulatory Information for NIKITA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-001 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-002 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lupin Ltd | NIKITA | pitavastatin sodium | TABLET;ORAL | 209875-003 | Aug 4, 2017 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |